The leading pharmaceutical company AstraZeneca will build their first ever manufacturing facility in Ireland with an investment of more than €300 million in Blanchardstown, Dublin. The facility to be built at the Alexion Campus in College Park will create 100 jobs and they will be producing active pharmaceutical ingredients (API) for small molecules.
According to Pascal Soriot, the CEO of the British-Swedish company, the project will nurture the country’s dynamic life sciences sector and allow for development of high value-added medicines. AstraZeneca is one of the leading manufacturers of Covid vaccines all across the world and one of the earlier developers of the vaccine.
Toiseach Michael Martin welcomed the announcement and said the project is a huge boost to the area and to the entire country’s life-science sector.